SG/CALL/BRISTOL-MYERS SQUIBB/70/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 15:36:04 2024-05-31 EDT | ||
| 0.001 EUR | -.--% |
|
| 6 months | -97.14% | ||
| Current year | -97.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.001 | -.--% |
| 24-05-30 | 0.001 | -.--% |
| 24-05-29 | 0.001 | -.--% |
| 24-05-28 | 0.001 | -.--% |
| 24-05-27 | 0.001 | -.--% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 03:36 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SQ8Z6N |
| ISIN | DE000SQ8Z6N5 |
| Date issued | 2023-02-13 |
| Strike | 70 $ |
| Maturity | 2024-09-20 (110 Days) |
| Parity | 10 : 1 |
| Emission price | 1 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.1 € |
|---|---|
| Lowest since issue | 0.001 € |
| Delta | 0.03x |
| Omega | 10.70 |
| Premium | 70.49x |
| Gearing | 361.06x |
| Moneyness | 0.5875 |
| Difference Strike | 28.88 $ |
| Difference Strike % | +41.25% |
| Spread | 0.019 € |
| Spread % | 95.00% |
| Intrinsic value | 0.000000 |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Warrants
- Warrant
